{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioavailability", "cancer chemoprevention", "multi-target agents", "nutritional therapy", "polyphenols", "stilbenes"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27148534", "DateCompleted": {"Year": "2016", "Month": "05", "Day": "05"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "04", "Day": "12"}], "ELocationID": ["8", "10.3389/fnut.2016.00008"], "Language": ["eng"], "Journal": {"ISSN": "2296-861X", "JournalIssue": {"Volume": "3", "PubDate": {"Year": "2016"}}, "Title": "Frontiers in nutrition", "ISOAbbreviation": "Front Nutr"}, "ArticleTitle": "Anticancer Molecular Mechanisms of Resveratrol.", "Pagination": {"StartPage": "8", "MedlinePgn": "8"}, "Abstract": {"AbstractText": ["Resveratrol is a pleiotropic phytochemical belonging to the stilbene family. Though it is only significantly present in grape products, a huge amount of preclinical studies investigated its anticancer properties in a plethora of cellular and animal models. Molecular mechanisms of resveratrol involved signaling pathways related to extracellular growth factors and receptor tyrosine kinases; formation of multiprotein complexes and cell metabolism; cell proliferation and genome instability; cytoplasmic tyrosine kinase signaling (cytokine, integrin, and developmental pathways); signal transduction by the transforming growth factor-\u03b2 super-family; apoptosis and inflammation; and immune surveillance and hormone signaling. Resveratrol also showed a promising role to counteract multidrug resistance: in adjuvant therapy, associated with 5-fluoruracyl and cisplatin, resveratrol had additive and/or synergistic effects increasing the chemosensitization of cancer cells. Resveratrol, by acting on diverse mechanisms simultaneously, has been emphasized as a promising, multi-target, anticancer agent, relevant in both cancer prevention and treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Universit\u00e0 degli Studi di Milano , Milan , Italy."}], "LastName": "Varoni", "ForeName": "Elena M", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Universit\u00e0 degli Studi di Milano , Milan , Italy."}], "LastName": "Lo Faro", "ForeName": "Alfredo Fabrizio", "Initials": "AF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran; Department of Pharmacognosy, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze Agrarie e Ambientali, Universit\u00e0 degli Studi di Milano , Milan , Italy."}], "LastName": "Iriti", "ForeName": "Marcello", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Nutr", "NlmUniqueID": "101642264", "ISSNLinking": "2296-861X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed (2015) 5:84\u201397.", "ArticleIdList": ["PMC4418057", "25949949"]}, {"Citation": "Rimando AM, Suh N. Biological/chemopreventive activity of stilbenes and their effect on colon cancer. Planta Med (2008) 74:1635\u201343.10.1055/s-0028-1088301", "ArticleIdList": ["10.1055/s-0028-1088301", "18843589"]}, {"Citation": "Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. Eur J Cancer Prev (2005) 14:139\u201342.10.1097/00008469-200504000-00009", "ArticleIdList": ["10.1097/00008469-200504000-00009", "15785317"]}, {"Citation": "Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila) (2009) 2:409\u201318.10.1158/1940-6207.CAPR-08-0160", "ArticleIdList": ["10.1158/1940-6207.CAPR-08-0160", "19401532"]}, {"Citation": "Varoni EM, Lodi G, Iriti M. Efficacy behind activity \u2013 phytotherapeutics are not different from pharmaceuticals. Pharm Biol (2015) 53:404\u20136.10.3109/13880209.2014.923000", "ArticleIdList": ["10.3109/13880209.2014.923000", "25472494"]}, {"Citation": "Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646\u201374.10.1016/j.cell.2011.02.013", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Lachenmeier DW, Godelmann R, Witt B, Riedel K, Rehm J. Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic \u00addose-response assessment. Int J Cancer (2014) 134:144\u201353.10.1002/ijc.28336", "ArticleIdList": ["10.1002/ijc.28336", "23784940"]}, {"Citation": "Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res (2005) 49:472\u201381.10.1002/mnfr.200500010", "ArticleIdList": ["10.1002/mnfr.200500010", "15779070"]}, {"Citation": "Zunino SJ, Storms DH. Physiological levels of resveratrol metabolites are ineffective as anti-leukemia agents against Jurkat leukemia cells. Nutr Cancer (2015) 67:266\u201374.10.1080/01635581.2015.989373", "ArticleIdList": ["10.1080/01635581.2015.989373", "25622018"]}, {"Citation": "Iriti I, Varoni E. Nutritional therapy: multitarget agents to prevent multifactorial diseases. Oncodrugs (2013) 1:1e\u20132e."}, {"Citation": "Iriti M, Varoni E. Biological and adjuvant therapies, new trends in oral cancer treatment. Oncodrugs (2014) 2:1e\u20132e."}, {"Citation": "Chun YJ, Kim MY, Guengerich FP. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun (1999) 262:20\u20134.10.1006/bbrc.1999.1152", "ArticleIdList": ["10.1006/bbrc.1999.1152", "10448061"]}, {"Citation": "Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR. Beneficial action of resveratrol: how and why? Nutrition (2016) 32:174\u20138.10.1016/j.nut.2015.08.017", "ArticleIdList": ["10.1016/j.nut.2015.08.017", "26706021"]}, {"Citation": "Iriti M, Faoro F. Health-promoting effects of grape bioactive phytochemicals. In: Watson RR, editor. Complementary and Alternative Therapies and the Aging Population. London: Academic Press; (2009). p. 445."}, {"Citation": "Britton RG, Kovoor C, Brown K. Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. Ann N Y Acad Sci (2015) 1348:124\u201333.10.1111/nyas.12796", "ArticleIdList": ["10.1111/nyas.12796", "26099829"]}, {"Citation": "Kubota T, Uemura Y, Kobayashi M, Taguchi H. Combined effects of resveratrol and paclitaxel on lung cancer cells. Anticancer Res (2003) 23:4039\u201346.", "ArticleIdList": ["14666716"]}, {"Citation": "Hogg SJ, Chitcholtan K, Hassan W, Sykes PH, Garrill A. Resveratrol, \u00adacetyl-resveratrol, and polydatin exhibit antigrowth activity against 3D cell aggregates of the SKOV-3 and OVCAR-8 ovarian cancer cell lines. Obstet Gynecol Int (2015) 2015:279591.10.1155/2015/279591", "ArticleIdList": ["10.1155/2015/279591", "PMC4651797", "26617640"]}, {"Citation": "Strickland LR, Pal HC, Elmets CA, Afaq F. Targeting drivers of melanoma with synthetic small molecules and phytochemicals. Cancer Lett (2015) 359:20\u201335.10.1016/j.canlet.2015.01.016", "ArticleIdList": ["10.1016/j.canlet.2015.01.016", "PMC4599342", "25597784"]}, {"Citation": "Wong JC, Fiscus RR. Resveratrol at anti-angiogenesis/anticancer concentrations suppresses protein kinase G signaling and decreases IAPs expression in HUVECs. Anticancer Res (2015) 35:273\u201381.", "ArticleIdList": ["25550561"]}, {"Citation": "Bommareddy A, Eggleston W, Prelewicz S, Antal A, Witczak Z, McCune DF, et al. Chemoprevention of prostate cancer by major dietary phytochemicals. Anticancer Res (2013) 33:4163\u201374.", "ArticleIdList": ["24122979"]}, {"Citation": "Bhattacharya S, Darjatmoko SR, Polans AS. Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res (2011) 21:180\u20137.10.1097/CMR.0b013e3283456dfc", "ArticleIdList": ["10.1097/CMR.0b013e3283456dfc", "PMC3086957", "21407133"]}, {"Citation": "Sengottuvelan M, Deeptha K, Nalini N. Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Chem Biol Interact (2009) 181:193\u2013201.10.1016/j.cbi.2009.06.004", "ArticleIdList": ["10.1016/j.cbi.2009.06.004", "19523937"]}, {"Citation": "Gu S, Chen C, Jiang X, Zhang Z. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells. Biol Trace Elem Res (2015) 163:112\u201323.10.1007/s12011-014-0186-2", "ArticleIdList": ["10.1007/s12011-014-0186-2", "25431299"]}, {"Citation": "Miku\u0142a-Pietrasik J, Sosi\u0144ska P, Murias M, Wierzchowski M, Brewi\u0144ska-Olchowik M, Piwocka K, et al. High potency of a novel resveratrol derivative, 3,3\u2019,4,4\u2019-Tetrahydroxy-trans-stilbene, against ovarian cancer is associated with an oxidative stress-mediated imbalance between DNA damage accumulation and repair. Oxid Med Cell Longev (2015) 2015:135691.10.1155/2015/135691", "ArticleIdList": ["10.1155/2015/135691", "PMC4502315", "26229578"]}, {"Citation": "Kucinska M, Piotrowska H, Luczak MW, Mikula-Pietrasik J, Ksiazek K, Wozniak M, et al. Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs. Chem Biol Interact (2014) 209:96\u2013110.10.1016/j.cbi.2013.12.009", "ArticleIdList": ["10.1016/j.cbi.2013.12.009", "24398169"]}, {"Citation": "Yu X-D, Yang J-L, Zhang W-L, Liu D-X. Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour Biol (2015):1\u20137.10.1007/s13277-015-3793-4", "ArticleIdList": ["10.1007/s13277-015-3793-4", "26409447"]}, {"Citation": "Chelsky ZL, Yue P, Kondratyuk TP, Paladino D, Pezzuto JM, Cushman M, et al. Resveratrol analogue promotes ERKMAPK-dependent Stat3 serine and tyrosine phosphorylation alterations and antitumor effects in vitro against human tumor cells. Mol Pharmacol (2015) 88:524\u201333.10.1124/mol.115.099093", "ArticleIdList": ["10.1124/mol.115.099093", "PMC4551051", "26138072"]}, {"Citation": "Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res (2001) 7:1466\u201373.", "ArticleIdList": ["11350919"]}, {"Citation": "Kuo P-L, Chiang L-C, Lin C-C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci (2002) 72:23\u201334.10.1016/S0024-3205(02)02177-X", "ArticleIdList": ["10.1016/S0024-3205(02)02177-X", "12409142"]}, {"Citation": "Liao P-C, Ng L-T, Lin L-T, Richardson CD, Wang G-H, Lin C-C. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food (2010) 13:1415\u201323.10.1089/jmf.2010.1126", "ArticleIdList": ["10.1089/jmf.2010.1126", "20946021"]}, {"Citation": "Adhami VM, Afaq F, Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun (2001) 288:579\u201385.10.1006/bbrc.2001.5819", "ArticleIdList": ["10.1006/bbrc.2001.5819", "11676482"]}, {"Citation": "Cosco D, Paolino D, Maiuolo J, Marzio LD, Carafa M, Ventura CA, et al. Ultradeformable liposomes as multidrug carrier of resveratrol and \u00ad5-fluorouracil for their topical delivery. Int J Pharm (2015) 489:1\u201310.10.1016/j.ijpharm.2015.04.056", "ArticleIdList": ["10.1016/j.ijpharm.2015.04.056", "25899287"]}, {"Citation": "Yu X-M, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther (2013) 12:1276\u201387.10.1158/1535-7163.MCT-12-0841", "ArticleIdList": ["10.1158/1535-7163.MCT-12-0841", "PMC3707971", "23594881"]}, {"Citation": "Polycarpou E, Meira LB, Carrington S, Tyrrell E, Modjtahedi H, Carew MA. Resveratrol 3-O-D-glucuronide and resveratrol 4\u2019-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Mol Nutr Food Res (2013) 57:1708\u201317.10.1002/mnfr.201200742", "ArticleIdList": ["10.1002/mnfr.201200742", "23650147"]}, {"Citation": "Yang T, Wang L, Zhu M, Zhang L, Yan L. Properties and molecular mechanisms of resveratrol: a review. Pharmazie (2015) 70:501\u20136.", "ArticleIdList": ["26380517"]}, {"Citation": "Basso E, Fiore M, Leone S, Degrassi F, Cozzi R. Effects of resveratrol on topoisomerase II-\u03b1 activity: induction of micronuclei and inhibition of chromosome segregation in CHO-K1 cells. Mutagenesis (2013) 28:243\u20138.10.1093/mutage/ges067", "ArticleIdList": ["10.1093/mutage/ges067", "23462849"]}, {"Citation": "Demoulin B, Hermant M, Castrogiovanni C, Staudt C, Dumont P. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis. Toxicol In Vitro (2015) 29:1156\u201365.10.1016/j.tiv.2015.04.015", "ArticleIdList": ["10.1016/j.tiv.2015.04.015", "25952326"]}, {"Citation": "Schroeter A, Groh IAM, Favero GD, Pignitter M, Schueller K, Somoza V, et al. Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells. Mol Nutr Food Res (2015) 12:2448\u201359.10.1002/mnfr.201500352", "ArticleIdList": ["10.1002/mnfr.201500352", "26455438"]}, {"Citation": "Rusin M, Zajkowicz A, Butkiewicz D. Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mech Ageing Dev (2009) 130:528\u201337.10.1016/j.mad.2009.06.005", "ArticleIdList": ["10.1016/j.mad.2009.06.005", "19559722"]}, {"Citation": "Leone S, Basso E, Polticelli F, Cozzi R. Resveratrol acts as a topoisomerase II poison in human glioma cells. Int J Cancer (2012) 131:E173\u20138.10.1002/ijc.27358", "ArticleIdList": ["10.1002/ijc.27358", "22095529"]}, {"Citation": "Lanzilli G, Fuggetta MP, Tricarico M, Cottarelli A, Serafino A, Falchetti R, et al. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol (2006) 28:641\u20138.", "ArticleIdList": ["16465368"]}, {"Citation": "Ren Z, Wang L, Cui J, Huoc Z, Xue J, Cui H, et al. Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities. Pharmazie (2013) 68:689\u201394.", "ArticleIdList": ["24020126"]}, {"Citation": "Buhrmann C, Shayan P, Kraehe P, Popper B, Goel A, Shakibaei M. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, epithelial-to-mesenchymal transition and apoptosis in colorectal cancer. Biochem Pharmacol (2015) 98:51\u201368.10.1016/j.bcp.2015.08.105", "ArticleIdList": ["10.1016/j.bcp.2015.08.105", "26310874"]}, {"Citation": "Bickenbach KA, Veerapong J, Shao MY, Mauceri HJ, Posner MC, Kron SJ, et al. Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther (2008) 15:133\u20139.10.1038/sj.cgt.7701103", "ArticleIdList": ["10.1038/sj.cgt.7701103", "18157146"]}, {"Citation": "Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, et al. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol (2011) 301:F427\u201335.10.1152/ajprenal.00258.2010", "ArticleIdList": ["10.1152/ajprenal.00258.2010", "21593185"]}, {"Citation": "Schirmer H, Pereira TCB, Rico EP, Rosemberg DB, Bonan CD, Bogo MR, et al. Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1\u03b1 and NAMPT gene expression profiles in wild-type adult zebrafish liver. Mol Biol Rep (2012) 39:3281\u20139.10.1007/s11033-011-1096-4", "ArticleIdList": ["10.1007/s11033-011-1096-4", "21706162"]}, {"Citation": "Thakur BK, Dittrich T, Chandra P, Becker A, Lippka Y, Selvakumar D, et al. Inhibition of NAMPT pathway by FK866 activates the function of p53 in HEK293T cells. Biochem Biophys Res Commun (2012) 424:371\u20137.10.1016/j.bbrc.2012.06.075", "ArticleIdList": ["10.1016/j.bbrc.2012.06.075", "22728882"]}, {"Citation": "Sin TK, Tam BT, Yu AP, Yip SP, Yung BY, Chan LW, et al. Acute treatment of resveratrol alleviates doxorubicin-induced myotoxicity in aged skeletal muscle through SIRT1-dependent mechanisms. J Gerontol A Biol Sci Med Sci (2015).10.1093/gerona/glv175", "ArticleIdList": ["10.1093/gerona/glv175", "PMC4888387", "26450947"]}, {"Citation": "Lou Y, Wang Z, Xu Y, Zhou P, Cao J, Li Y, et al. Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. Int J Mol Med (2015) 36:873\u201380.10.3892/ijmm.2015.2291", "ArticleIdList": ["10.3892/ijmm.2015.2291", "26202177"]}, {"Citation": "Shi Q, Geldenhuys W, Sutariya V, Bishayee A, Patel I, Bhatia D. CArG-driven GADD45\u03b1 activated by resveratrol inhibits lung cancer cells. Genes Cancer (2015) 6:220\u201330.", "ArticleIdList": ["PMC4482243", "26124921"]}, {"Citation": "Yang Z, Yang S, Misner BJ, Chiu R, Liu F, Meyskens FL. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther (2008) 7:3751\u201360.10.1158/1535-7163.MCT-08-0562", "ArticleIdList": ["10.1158/1535-7163.MCT-08-0562", "19074850"]}, {"Citation": "Li W, Ma J, Ma Q, Li B, Han L, Liu J, et al. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-\u03baB pathway. Curr Med Chem (2013) 20:4185\u201394.10.2174/09298673113209990251", "ArticleIdList": ["10.2174/09298673113209990251", "PMC4085327", "23992306"]}, {"Citation": "Zhong L-X, Li H, Wu M-L, Liu X-Y, Zhong M-J, Chen X-Y, et al. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells. J Ovarian Res (2015) 8:25.10.1186/s13048-015-0152-4", "ArticleIdList": ["10.1186/s13048-015-0152-4", "PMC4409989", "25896424"]}, {"Citation": "Miku\u0142a-Pietrasik J, Sosi\u0144ska P, Ksia\u017cek K. Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of \u03b15\u03b21 integrins and hyaluronic acid. Gynecol Oncol (2014) 134:624\u201330.10.1016/j.ygyno.2014.06.022", "ArticleIdList": ["10.1016/j.ygyno.2014.06.022", "24995580"]}, {"Citation": "Gao Q, Yuan Y, Gan H-Z, Peng Q. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol Lett (2015) 9:2381\u20137.10.3892/ol.2015.2988", "ArticleIdList": ["10.3892/ol.2015.2988", "PMC4467343", "26137075"]}, {"Citation": "Qin Y, Ma Z, Dang X, Li W, Ma Q. Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the hedgehog signaling pathway. Mol Med Rep (2014) 10:2563\u20137.10.3892/mmr.2014.2511", "ArticleIdList": ["10.3892/mmr.2014.2511", "25190613"]}, {"Citation": "Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, et al. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res (2009) 1:25\u201337.", "ArticleIdList": ["PMC3004662", "21188121"]}, {"Citation": "Zhang P, Li H, Yang B, Yang F, Zhang L-L, Kong Q-Y, et al. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer (2014) 5:154\u201364.", "ArticleIdList": ["PMC4104760", "25061499"]}, {"Citation": "Lin H, Xiong W, Zhang X, Liu B, Zhang W, Zhang Y, et al. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep (2011) 26:925\u201330.10.3892/or.2011.1380", "ArticleIdList": ["10.3892/or.2011.1380", "21743969"]}, {"Citation": "Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-\u03b21/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer (2015) 15:97.10.1186/s12885-015-1119-y", "ArticleIdList": ["10.1186/s12885-015-1119-y", "PMC4362662", "25884904"]}, {"Citation": "Shankar S, Chen Q, Siddiqui I, Sarva K, Srivastava RK. Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4\u2019, 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential. J Mol Signal (2007) 2:7.10.1186/1750-2187-2-7", "ArticleIdList": ["10.1186/1750-2187-2-7", "PMC2018690", "17718901"]}, {"Citation": "Shankar S, Siddiqui I, Srivastava RK. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol Cell Biochem (2007) 304:273\u201385.10.1007/s11010-007-9510-x", "ArticleIdList": ["10.1007/s11010-007-9510-x", "17636462"]}, {"Citation": "Harati K, Slodnik P, Chromik AM, Goertz O, Hirsch T, Kapalschinski N, et al. Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Anticancer Res (2015) 35:767\u201374.", "ArticleIdList": ["25667456"]}, {"Citation": "Ma L, Li W, Wang R, Nan Y, Wang Q, Liu W, et al. Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis. Int J Oncol (2015) 47:1460\u20138.10.3892/ijo.2015.3124", "ArticleIdList": ["10.3892/ijo.2015.3124", "26314326"]}, {"Citation": "Cai Y, Zhao L, Qin Y, Zhang M, He Y. Resveratrol inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cell line C666-1 through AMPK activation. Pharmazie (2015) 70:399\u2013403.", "ArticleIdList": ["26189302"]}, {"Citation": "Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, et al. A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol (2015) 35(Suppl):S151\u201384.10.1016/j.semcancer.2015.03.006", "ArticleIdList": ["10.1016/j.semcancer.2015.03.006", "PMC4635070", "25951989"]}, {"Citation": "Latruffe N, Lan\u00e7on A, Frazzi R, Aires V, Delmas D, Michaille J-J, et al. Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation. Ann N Y Acad Sci (2015) 1348:97\u2013106.10.1111/nyas.12819", "ArticleIdList": ["10.1111/nyas.12819", "26190093"]}, {"Citation": "Inoue H, Nakata R. Resveratrol targets in inflammation. Endocr Metab Immune Disord Drug Targets (2015) 15:186\u201395.10.2174/1871530315666150316120316", "ArticleIdList": ["10.2174/1871530315666150316120316", "25772176"]}, {"Citation": "Fajardo AM, Piazza GA. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention. Am J Physiol Gastrointest Liver Physiol (2015) 309:G59\u201370.10.1152/ajpgi.00101.2014", "ArticleIdList": ["10.1152/ajpgi.00101.2014", "PMC4504955", "26021807"]}, {"Citation": "Chin Y-T, Yang S-H, Chang T-C, Changou CA, Lai H-Y, Fu E, et al. Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ER\u03b1 status. Oncotarget (2015) 6:35866\u201379.10.18632/oncotarget.5482", "ArticleIdList": ["10.18632/oncotarget.5482", "PMC4742147", "26456774"]}, {"Citation": "Jeong SK, Yang K, Park YS, Choi YJ, Oh SJ, Lee CW, et al. Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages. Int Immunopharmacol (2014) 22:303\u201310.10.1016/j.intimp.2014.07.004", "ArticleIdList": ["10.1016/j.intimp.2014.07.004", "25042796"]}, {"Citation": "Ruotolo R, Calani L, Fietta E, Brighenti F, Crozier A, Meda C, et al. Anti-estrogenic activity of a human resveratrol metabolite. Nutr Metab Cardiovasc Dis (2013) 23:1086\u201392.10.1016/j.numecd.2013.01.002", "ArticleIdList": ["10.1016/j.numecd.2013.01.002", "23465317"]}, {"Citation": "Zhang S, Cao HJ, Davis FB, Tang H-Y, Davis PJ, Lin H-Y. Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells. Br J Cancer (2004) 91:178\u201385.10.1038/sj.bjc.6601902", "ArticleIdList": ["10.1038/sj.bjc.6601902", "PMC2364738", "15188005"]}, {"Citation": "Kjaer TN, Ornstrup MJ, Poulsen MM, J\u00f8rgensen JOL, Hougaard DM, Cohen AS, et al. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men. Prostate (2015) 75:1255\u201363.10.1002/pros.23006", "ArticleIdList": ["10.1002/pros.23006", "25939591"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "1", "Day": "10"}, {"Year": "2016", "Month": "3", "Day": "23"}, {"Year": "2016", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["27148534", "PMC4828556", "10.3389/fnut.2016.00008"]}}], "PubmedBookArticle": []}